康泰生物 (300601.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(康泰生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度销售毛利率(%) 84.0087.0086.0072.0088.0087.0086.00
 单季度销售净利率(%) 25.0031.0027.00-57.0011.00-16.0031.00
 单季度净资产收益率ROE(%) 2.003.002.00-4.001.00-2.003.00
 单季度总资产净利率ROA(%) 1.002.001.00-2.001.00-1.002.00
单季度财务摘要:
 单季度营业总收入(元) 733,895,892.00982,185,585.00748,383,301.00592,337,677.00737,220,177.00956,418,403.00871,425,499.00
 单季度营业总成本(元) 551,578,004.00678,254,580.00502,644,829.00636,396,273.00669,230,185.00750,664,620.00561,389,214.00
 单季度营业收入(元) 733,895,892.00982,185,585.00748,383,301.00592,337,677.00737,220,177.00956,418,403.00871,425,499.00
 单季度营业利润(元) 202,392,855.00322,009,215.00244,347,203.00-470,159,734.0064,346,907.00-238,959,276.00327,201,104.00
 单季度利润总额(元) 201,242,000.00321,942,443.00241,818,059.00-481,519,778.0058,681,609.00-237,408,705.00322,000,412.00
 单季度净利润(元) 186,619,347.00304,968,697.00205,462,820.00-335,854,956.0082,644,272.00-153,085,495.00273,588,320.00
 单季度归属母公司股东的净利润(元) 186,619,347.00304,968,697.00205,462,820.00-335,854,956.0082,644,272.00-153,085,495.00273,588,320.00
 单季度经营活动产生的现金流量(元) 286,521,445.00210,654,097.00128,596,485.00284,867,330.00153,032,057.00168,435,974.00-60,639,410.00
 单季度投资活动产生的现金流量(元) -30,025,603.00-388,884,737.0037,700,645.00-445,983,563.00-1,398,270,930.00-338,425,207.00-423,624,297.00
 单季度筹资活动产生的现金流量(元) -169,122.00682,373.00-230,650,719.00-43,484,379.00-151,456,602.00-245,806,068.00-24,128,956.00
 单季度现金及现金等价物净增加(元) 256,317,105.00-177,486,627.00-64,353,970.00-204,601,299.00-1,396,649,591.00-415,790,381.00-510,105,564.00

前瞻产业研究院